APA (7th ed.) Citation

A, O., B, K., DT, S., M, P., A, B., E, A., . . . S, D. (2021). T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nature communications, 12(1), 2055. https://doi.org/10.1038/s41467-021-21856-3

Chicago Style (17th ed.) Citation

A, Ogbe, et al. "T Cell Assays Differentiate Clinical and Subclinical SARS-CoV-2 Infections from Cross-reactive Antiviral Responses." Nature Communications 12, no. 1 (2021): 2055. https://doi.org/10.1038/s41467-021-21856-3.

MLA (9th ed.) Citation

A, Ogbe, et al. "T Cell Assays Differentiate Clinical and Subclinical SARS-CoV-2 Infections from Cross-reactive Antiviral Responses." Nature Communications, vol. 12, no. 1, 2021, p. 2055, https://doi.org/10.1038/s41467-021-21856-3.